Structure-based design of protein-tyrosine phosphatase inhibitors.

被引：0
|
作者：
Moller, NPH
Iversen, LF
Hansen, TK
Lau, J
Petersen, AK
Olsen, OH
Moller, KB
Mortensen, SB
Billestrup, N
Ge, Y
Newman, MJ
Holsworth, DD
Lund, IK
Andersen, B
Peters, GH
Andersen, HS
机构：
[1] Novo Nordisk AS, Signal Transduct, DK-2880 Bagsvaerd, Denmark
[2] Novo Nordisk AS, Prot Struct, DK-2880 Bagsvaerd, Denmark
[3] Novo Nordisk AS, Med Chem Res 4, DK-2880 Bagsvaerd, Denmark
[4] Novo Nordisk AS, Med Chem Res 1, DK-2880 Bagsvaerd, Denmark
[5] Novo Nordisk AS, Discovery Biol, DK-2880 Bagsvaerd, Denmark
[6] Tech Univ Denmark, Dept Chem, Lyngby, Denmark
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2002年 / 223卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
264-MEDI
引用
收藏
页码：B143 / B143
页数：1
相关论文
共 50 条
  • [21] Solid-phase synthesis of phenyl(difluoromethyl)phosphonic acids as potential protein-tyrosine phosphatase inhibitors.
    Li, ZG
    Ganesan, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U910 - U910
  • [22] Structure-Based Optimization of Benzoic Acids as Inhibitors of Protein Tyrosine Phosphatase 1B and Low Molecular Weight Protein Tyrosine Phosphatase
    Maccari, Rosanna
    Ottana, Rosaria
    Ciurleo, Rosella
    Paoli, Paolo
    Manao, Giampaolo
    Camici, Guido
    Laggner, Christian
    Langer, Thierry
    CHEMMEDCHEM, 2009, 4 (06) : 957 - 962
  • [23] Structure-based design and discovery of novel inhibitors of protein tyrosine phosphatases.
    Huang, P
    Ramphal, J
    Liang, C
    Wei, J
    McMahon, G
    Tang, C
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : U498 - U498
  • [24] Structure-based design of a low molecular weight, nonphosphorus, nonpeptide, and highly selective inhibitor of protein-tyrosine phosphatase 1B
    Iversen, LF
    Andersen, HS
    Branner, S
    Mortensen, SB
    Peters, GH
    Norris, K
    Olsen, OH
    Jeppesen, CB
    Lundt, BF
    Ripka, W
    Moller, KB
    Moller, NPH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (14) : 10300 - 10307
  • [25] Structure-based De novo design of estrone sulfatase inhibitors.
    Ghosh, D
    Ghosh, D
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9052S - 9052S
  • [26] De novo structure-based design of factor XA inhibitors.
    Cheney, DL
    Mason, JS
    Becker, MR
    Ewing, RW
    Pauls, HW
    Todorov, N
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U861 - U861
  • [27] Structure-based discovery and development of selective protein kinase inhibitors.
    Rose, PE
    Begley, M
    Boucher, CE
    Carney, D
    Daniell, T
    Kim, J
    Morgenstern, K
    Stover, D
    Toledo, L
    Zhao, H
    Zhu, X
    CLINICAL CANCER RESEARCH, 1999, 5 : 3753S - 3753S
  • [28] Structure-based design of orally bioavailable cathepsin K inhibitors.
    Thompson, SK
    Michaud, E
    Halbert, SM
    Tomaszek, TA
    Tew, DG
    Zhao, BG
    Smith, WW
    Janson, CA
    D'Alessio, KJ
    McQueney, MS
    Kurdyla, J
    Jones, CS
    Abdel-Meguid, SS
    Ijames, CF
    DesJarlais, RL
    Salyers, KL
    Smith, BR
    Levy, MA
    Veber, DF
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1157 - U1157
  • [29] Structure-based design, synthesis, and evaluation of amyloid fibril inhibitors.
    Kelly, JW
    Petrassi, HM
    Oza, V
    Purkey, H
    Koepf, E
    Raman, P
    Klabunde, T
    Sacchettini, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U201 - U201
  • [30] Structure determination of T cell protein-tyrosine phosphatase
    Iversen, LF
    Moller, KB
    Pedersen, AK
    Peters, GH
    Petersen, AS
    Andersen, HS
    Branner, S
    Mortensen, SB
    Moller, NPH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (22) : 19982 - 19990
12345